“Integrated Network Pharmacology, ADMET Profiling, and Molecular Docking Investigation of Losartan and Its Active Metabolite Against Angiotensin-Related Target”. International Journal of Pharmaceutical Research and Medicinal Plants, vol. 2, no. 5, Oct. 2026, pp. 76-82, https://doi.org/10.61280/4sa10p81.